These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24525359)

  • 1. Automated mass screening and association rules analysis for comorbidities of psoriasis: A population-based case-control study.
    Kim BR; Lee KH; Paik K; Kim M; Bae JM; Choi CW; Youn SW
    J Dermatol; 2024 Apr; 51(4):539-551. PubMed ID: 38345288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
    Sajja AP; Joshi AA; Teague HL; Dey AK; Mehta NN
    Front Immunol; 2018; 9():1234. PubMed ID: 29910818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis-associated vascular disease: the role of HDL.
    Paiva-Lopes MJ; Delgado Alves J
    J Biomed Sci; 2017 Sep; 24(1):73. PubMed ID: 28911329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis.
    Song WB; Soffer DE; Gelfand JM
    Dermatol Clin; 2024 Jul; 42(3):417-428. PubMed ID: 38796273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasis Comorbidities and Their Treatment Impact.
    Taliercio M; Lebwohl M
    Dermatol Clin; 2024 Jul; 42(3):405-416. PubMed ID: 38796272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Care Coordination Model to Prevent Cardiovascular Events in Patients with Psoriatic Disease: A Multicenter Pilot Study.
    Song WB; Garshick MS; Barbieri JS; Shin DB; Báez S; Papadopoulos M; Neopaney A; Fitzsimmons R; Kalb RE; Mease PJ; Craig ET; Koplin J; Takeshita J; Chiesa Fuxench ZC; Armstrong AW; Mehta NN; Beidas RS; Ogdie AR; Gelfand JM
    J Invest Dermatol; 2024 Jun; 144(6):1405-1409.e1. PubMed ID: 38184142
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel biomarkers and psoriasis associated cardiovascular risk.
    Fernández-Domper L; Martin-Hernández JM; Páramo JA; Fernandez-Alonso L; Martínez-Casimiro L; Montesinos-Villaescusa E; Revert-Fernández Á; Morales-Suarez-Varela M
    Arch Dermatol Res; 2024 May; 316(5):140. PubMed ID: 38695963
    [No Abstract]   [Full Text] [Related]  

  • 8. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
    Ryan C; Kirby B
    Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.
    Ganzetti G; Campanati A; Molinelli E; Offidani A
    World J Cardiol; 2016 Feb; 8(2):120-31. PubMed ID: 26981209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Successful combination treatment for psoriasis with phototherapy and low-dose cytokines: A spontaneous, retrospective observational clinical study].
    Lotti T
    Hautarzt; 2015 Nov; 66(11):849-54. PubMed ID: 26449546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease and psoriasis: So far, so near.
    Ganzetti G; Campanati A; Offidani A
    World J Hepatol; 2015 Mar; 7(3):315-26. PubMed ID: 25848461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psoriasis and cardiovascular disease].
    Torres T; Sales R; Vasconcelos C; Selores M
    Acta Med Port; 2013; 26(5):601-7. PubMed ID: 24192101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk and psoriasis: beyond the traditional risk factors.
    Coumbe AG; Pritzker MR; Duprez DA
    Am J Med; 2014 Jan; 127(1):12-8. PubMed ID: 24161194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoriasis strikes back! Epicardial adipose tissue: another contributor to the higher cardiovascular risk in psoriasis.
    Raposo I; Torres T
    Rev Port Cardiol; 2015 Oct; 34(10):613-6. PubMed ID: 26417656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.
    Hu SC; Lan CE
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29065479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis: the visible killer.
    Torres T; Bettencourt N
    Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.